Over the last two decades changes in technology and policy have altered the landscape of drug discovery. These changes have led to concerns that the patent system may be creating difficulties for those trying to do research in biomedical fields. Using interviews and archival data, this paper examines the changes in patenting in recent years and how these have affected innovation in pharmaceuticals and related biotech industries.
Adobe .pdf files require the Adobe Acrobat Reader.
Download and install the Adobe Acrobat Reader.